A bill to prohibit price gouging in the sale of drugs.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Senior Senator for Connecticut. Democrat.
Last Updated: Dec 13, 2018
Length: 7 pages
115th Congress, 2017–2019
This bill was introduced on December 13, 2018, in a previous session of Congress, but was not enacted.
Dec 13, 2018
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
Feb 28, 2019
Reintroduced Bill — Introduced
This activity took place on a related bill, S. 637.
S. 3754 (115th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 115th Congress, which met from Jan 3, 2017 to Jan 3, 2019. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
GovTrack.us. (2019). S. 3754 — 115th Congress: CURE High Drug Prices Act. Retrieved from https://www.govtrack.us/congress/bills/115/s3754
“S. 3754 — 115th Congress: CURE High Drug Prices Act.” www.GovTrack.us. 2018. October 22, 2019 <https://www.govtrack.us/congress/bills/115/s3754>
CURE High Drug Prices Act, S. 3754, 115th Cong. (2018).
|title=S. 3754 (115th)
|accessdate=October 22, 2019
|author=115th Congress (2018)
|date=December 13, 2018
|quote=CURE High Drug Prices Act
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.